Panacea Life Sciences Holdings (Panacea Life Sciences Holdings) Beneish M-Score : -4.36 (As of May. 16, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Panacea Life Sciences Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.36 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Panacea Life Sciences Holdings's Beneish M-Score or its related term are showing as below:

PLSH' s Beneish M-Score Range Over the Past 10 Years
Min: -5.42 Med: -3.94 Max: -3.68
Current: -4.36

During the past 4 years, the highest Beneish M-Score of Panacea Life Sciences Holdings was -3.68. The lowest was -5.42. And the median was -3.94.

Panacea Life Sciences Holdings Beneish M-Score Historical Data

The historical data trend for Panacea Life Sciences Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Life Sciences Holdings Beneish M-Score Chart

Panacea Life Sciences Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Beneish M-Score

-3.83

-4.35

Panacea Life Sciences Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beneish M-Score	Get a 7-Day Free Trial											-3.68	-3.78	-3.68	-4.35	-4.36

Competitive Comparison of Panacea Life Sciences Holdings's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panacea Life Sciences Holdings's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Panacea Life Sciences Holdings's Beneish M-Score falls into.

Panacea Life Sciences Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Panacea Life Sciences Holdings for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 0.2325

0.528 * 0.5023

0.404 * 1.4678

0.892 * 1.5041

0.115 * 0.972

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 1.0879

4.679 * -0.307414

0.327 * 1.2887

-4.36

This Year (Mar24) TTM:

Last Year (Mar23) TTM:

Total Receivables was $0.27 Mil.
Revenue was 1.056 + 0.96 + 0.348 + 0.399 = $2.76 Mil.
Gross Profit was 0.666 + 0.547 + 0.147 + 0.203 = $1.56 Mil.
Total Current Assets was $4.64 Mil.
Total Assets was $17.41 Mil.
Property, Plant and Equipment(Net PPE) was $9.76 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.67 Mil.
Selling, General, & Admin. Expense(SGA) was $1.46 Mil.
Total Current Liabilities was $20.39 Mil.
Long-Term Debt & Capital Lease Obligation was $6.64 Mil.
Net Income was -1.446 + -2.209 + -2.151 + -1.864 = $-7.67 Mil.
Non Operating Income was 0.041 + -0.028 + -0.34 + -0.423 = $-0.75 Mil.
Cash Flow from Operations was -0.357 + 0.002 + -0.729 + -0.483 = $-1.57 Mil.

Total Receivables was $0.78 Mil.
Revenue was 0.677 + 0.325 + 0.366 + 0.469 = $1.84 Mil.
Gross Profit was 0.226 + 0.111 + 0.047 + 0.138 = $0.52 Mil.
Total Current Assets was $5.95 Mil.
Total Assets was $18.56 Mil.
Property, Plant and Equipment(Net PPE) was $10.42 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.73 Mil.
Selling, General, & Admin. Expense(SGA) was $0.89 Mil.
Total Current Liabilities was $15.89 Mil.
Long-Term Debt & Capital Lease Obligation was $6.47 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.271 / 2.763)	/	(0.775 / 1.837)
	=	0.098082	/	0.421884
	=	0.2325

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0.522 / 1.837)	/	(1.563 / 2.763)
	=	0.284159	/	0.565689
	=	0.5023

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (4.643 + 9.755) / 17.413)	/	(1 - (5.947 + 10.421) / 18.557)
	=	0.173146	/	0.117961
	=	1.4678

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	2.763	/	1.837
	=	1.5041

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(1.73 / (1.73 + 10.421))	/	(1.674 / (1.674 + 9.755))
	=	0.142375	/	0.14647
	=	0.972

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(1.458 / 2.763)	/	(0.891 / 1.837)
	=	0.527687	/	0.48503
	=	1.0879

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((6.643 + 20.392) / 17.413)	/	((6.467 + 15.89) / 18.557)
	=	1.552576	/	1.204774
	=	1.2887

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-7.67 - -0.75	-	-1.567)	/	17.413
	=	-0.307414

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Panacea Life Sciences Holdings has a M-score of -4.36 suggests that the company is unlikely to be a manipulator.

Panacea Life Sciences Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Panacea Life Sciences Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacea Life Sciences Holdings (Panacea Life Sciences Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Panacea Life Sciences Holdings Inc (OTCPK:PLSH) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

5910 S University Boulevard, C18-193, Greenwood Village, CO, USA, 80121

Website

https://www.panacealife.com

Panacea Life Sciences Holdings Inc is a cannabinoid nutraceutical manufacturer and research company that produces natural pharmaceutical alternatives for consumers and pets. It manufactures and sells soft gels, gummies, tinctures, sublingual tablets, cosmetics, and other topicals.

Executives

Leslie Buttorff	director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER	16194 W 45TH DRIVE, GOLDEN CO 80403
Janice Nerger	director	5910 S UNIVERSITY BLVD., C18-193, GREENWOOD VILLAGE CO 80121
Nathan Joel Berman	officer: CONTROLLER & PRIN ACTNG OFCR	16194 W 45TH DRIVE, GOLDEN CO 80403
22nd Century Group, Inc.	10 percent owner	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Harvey J Kesner	10 percent owner	65 E. 55TH STREET, NEW YORK NY 10022
Lawrence Wert	director	170 NUTTALL RD, RIVERSIDE IL 60546
Chesne Derek Du	officer: Chief Growth Officer	80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483
Alvaro Daniel Alberttis	director	80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483
Vladislav Yampolsky	director, 10 percent owner	332 PLAZA REAL, BOCA RATON FL 33432
Steven A Schwartz	director	332 PLAZA REAL, BOCA RATON FL 33432
Andrew L. Johnson	officer: Chief Strategy Officer	80 NE 4TH AVE. SUITE 28, DELRAY BEACH FL 33483
Emiliano Angel Aloi	officer: President	510 SUNSHINE DRIVE, DELRAY BEACH FL 33444
Jonathan Gilbert	director, officer: Executive Chairman	36 SYCAMORE LANE, ROSALYN HEIGHTS NY 11577
John C Price	director	4721 IRONTON STREET, BUILDING A, DENVER CO 80239
Kevin James Esval	director	NEURO HITECH INC, ONE PENN PLAZA STE 1503, NEW YORK NY 10019